Skip to search formSkip to main contentSkip to account menu

Teceleukin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Inhibition of the constitutively active kinase BCR-ABL1 with tyrosine kinase inhibitors(TKIs) contributed to a remarkable… 
2004
2004
4670 Background: In Japan, the officially recommended dose of interleukin-2 (IL-2) is low as less than one tenth of that in U.S.A… 
2000
2000
se of drug eruption after long term rIL-2 therapy is reported.A 67-year-old man had a tumor on his right temporal scalp on June… 
1989
1989
Single doses of teceleukin ranging from 0.1 to 30 x 10(6) units were administered to cancer patients as intravenous infusions or… 
1989
1989
Single doses of teceleukin ranging from 0.1 to 30 x 10(6) units were administered to cancer patients as intravenous infusions or…